Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | CRHBP | P24387 | 1/20 | 0.30 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL718437 | 0.94 | BACE1 (0.50) | BACE1CYP1A1CYP1B1HDAC8ALDH1A1 | |
| SCHEMBL211753 | 0.83 | CYP1A1 (0.46) | CYP1A1CYP1B1HDAC8CA12CA1 | |
| SCHEMBL2813175 | 0.82 | CA12 (0.55) | BACE1CYP1A1CYP1B1CA12CA1 | |
| SCHEMBL7039619 | 0.82 | ALDH1A1 (0.55) | BACE1CYP1A1CYP1B1ALDH1A1CYP3A4 | |
| SCHEMBL7034739 | 0.82 | HCAR1 (0.40) | BACE1CYP1A1CYP1B1ALDH1A1CYP3A4 | |
| SCHEMBL7038977 | 0.77 | CYP3A4 (0.45) | BACE1CYP1A1CYP1B1ALDH1A1CA1 | |
| SCHEMBL1620474 | 0.77 | ALDH5A1 (0.38) | ALDH1A1CA12CA1CA9CYP3A4 | |
| Methylamine SCHEMBL29029240 | 0.73 | CYP1A1 (0.40) | CYP1A1CYP1B1HDAC8CA12CA1 | |
| SCHEMBL77655 | 0.73 | — | — | |
| SCHEMBL30063924 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4279913-A2 | ACOUSTIC WAVE SENSORS AND METHODS OF SENSING A GAS-PHASE ANALYT | Rohm and Haas Electronic Materials LLC (US) | 2023-11-22 | — | — | EP | disclosed |
| EP-3511709-B1 | ACOUSTIC WAVE SENSORS AND METHODS OF SENSING A GAS-PHASE ANALYTE | ROHM & HAAS ELECT MAT (US) | 2023-11-01 | — | — | EP | disclosed |
| US-11746254-B2 | Tunable refractive index polymers | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2023-09-05 | — | — | US | disclosed |
| US-11746254-B2 | Tunable refractive index polymers | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2023-09-05 | — | — | US | disclosed |
| US-20220197142-A1 | PHOTORESIST UNDERLAYER COMPOSITIONS AND PATTERNING METHODS | ROHM AND HAAS ELECTRONIC MATERIALS LLC | 2022-06-23 | — | — | US | disclosed |
| CN-114647152-A | Photoresist underlayer composition and patterning method | 罗门哈斯电子材料有限责任公司 | 2022-06-21 | — | — | CN | disclosed |
| US-20210147707-A1 | TUNABLE REFRACTIVE INDEX POLYMERS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2021-05-20 | — | — | US | disclosed |
| CN-108218695-B | Polyarylene resins | 罗门哈斯电子材料有限责任公司 | 2021-04-16 | — | — | CN | disclosed |
| US-10894848-B2 | Polyarylene resins | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2021-01-19 | — | — | US | disclosed |
| CN-108148194-B | Aromatic resin for underlayer | 罗门哈斯电子材料有限责任公司 | 2020-11-10 | — | — | CN | disclosed |
| US-20170009006-A1 | POLYARYLENE MATERIALS | ROHM AND HAAS ELECTRONIC MATERIALS LLC | 2017-01-12 | — | — | US | disclosed |
| EP-3115392-A1 | POLYARYLENE MATERIALS | Rohm and Haas Electronic Materials LLC (US) | 2017-01-11 | — | — | EP | disclosed |
| EP-3115392-A1 | POLYARYLENE MATERIALS | Rohm and Haas Electronic Materials LLC (US) | 2017-01-11 | — | — | EP | disclosed |
| US-20100286353-A1 | ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF | FUJIFILM CORPORATION (JP) | 2010-11-11 | — | — | US | disclosed |
| CN-101868444-A | Acetylenic compound, salt thereof, condensate thereof, and composition thereof | FUJIFILM CORP | 2010-10-20 | — | — | CN | disclosed |
| US-20100240908-A1 | ACETYLENE COMPOUND | FUJIFILM CORPORATION (JP) | 2010-09-23 | — | — | US | disclosed |
| CN-101808982-A | Acetylene compound | FUJIFILM CORP | 2010-08-18 | — | — | CN | disclosed |
| EP-2202220-A1 | ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF | Fujifilm Corporation (JP) | 2010-06-30 | — | — | EP | disclosed |
| EP-2202221-A1 | ACETYLENE COMPOUND | Fujifilm Corporation (JP) | 2010-06-30 | — | — | EP | disclosed |
| US-20030065117-A1 | Modified silicone compound, process of producing the same, and cured object obtained therefrom | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2003-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240908-A1 | ACETYLENE COMPOUND | NAT1, KATNA1, KAT2B | BACE1 3162/4885CYP1A1 107/4885CYP1B1 134/4885 |
| US-10894848-B2 | Polyarylene resins | PIN1, HSD17B12, PCBP1 | BACE1 3323/4885CYP1A1 220/4885CYP1B1 221/4885 |
| US-20100286353-A1 | ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF | KAT8, HDAC10, SSRP1 | BACE1 3680/4885CYP1A1 2489/4885CYP1B1 3236/4885 |
| US-20030065117-A1 | Modified silicone compound, process of producing the same, and cured object obtained therefrom | ORMDL3, SGMS1, HEATR1 | BACE1 3480/4885CYP1A1 2234/4885CYP1B1 1741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.